Product Code: HIT 9452
The global enterprise imaging IT market is projected to reach USD 4.59 billion by 2031, up from USD 2.58 billion in 2026, at a CAGR of 12.2% from 2026 to 2031. Growth in the enterprise imaging IT market is driven by rising diagnostic imaging volumes, the increasing complexity of imaging data, and the need to improve the accessibility, management, and security of medical images across healthcare networks. More than 3.6 billion diagnostic radiology examinations are performed worldwide annually, generating large and continuously expanding volumes of imaging data that require scalable storage, interoperability, and enterprise-wide access.
| Scope of the Report |
| Years Considered for the Study | 2026-2031 |
| Base Year | 2025 |
| Forecast Period | 2026-2031 |
| Units Considered | Value (USD billion) |
| Segments | Function, modality, application, offering, deployment mode, therapeutic area, end user |
| Regions covered | North America, Europe, Asia Pacific, Latin America and Middle East & Africa |
The scale of imaging repositories is further illustrated by Scotland's national medical imaging archive, which contains approximately 2.47 billion DICOM images across 57.3 million studies, highlighting the growing data-management requirements of healthcare systems. Imaging activity is also increasing in the US, where FDA data indicate that more than 45 million mammography procedures were reported annually as of September 2026, across 9,128 certified facilities and 27,793 accredited units. These trends are increasing demand for enterprise imaging platforms, vendor-neutral archives, cloud-based storage, and interoperable image exchange solutions. However, adoption remains constrained by cybersecurity and integration challenges, as demonstrated by an HHS investigation involving a radiology provider whose PACS server breach exposed medical images of 21,778 individuals.
"In 2025, on-premises deployment constituted the largest segment in the enterprise imaging IT market, by deployment mode"
By deployment mode, on-premise solutions represented the largest share of the enterprise imaging IT market in 2025. Their leadership stems from hospitals and large healthcare organizations' continued preference for greater control over sensitive medical imaging data, IT infrastructure, security, and system performance. On-premises enterprise imaging platforms enable healthcare providers to keep imaging data within their own infrastructure while integrating with existing PACS, RIS, EHR, and clinical systems. The need to comply with data privacy and healthcare regulations, particularly for organizations with stringent data residency and security requirements, further supports adoption. Moreover, established investments in legacy imaging infrastructure and the high costs and complexity of migrating large imaging archives to the cloud are encouraging healthcare organizations to continue using on-premises solutions. However, increasing demand for scalability, remote image access, reduced infrastructure maintenance, and AI-enabled imaging workflows is expected to support a gradual shift toward cloud-based deployment during the forecast period.
"The oncology segment by therapeutic area is expected to register the fastest growth during the forecast period."
By therapeutic area, oncology is expected to be the fastest-growing segment of the enterprise imaging IT market, driven by the growing use of medical imaging for cancer screening, diagnosis, staging, treatment planning, and monitoring. The rising prevalence of cancer and demand for advanced imaging modalities, including CT, MRI, PET, and molecular imaging, are generating substantial volumes of oncology-related imaging data. Enterprise imaging platforms enable healthcare organizations to centrally store, access, share, and analyze these images across multidisciplinary oncology teams and care settings. Furthermore, the growing adoption of AI-enabled imaging for tumor detection, lesion characterization, treatment response assessment, and workflow prioritization is supporting demand for integrated imaging solutions. The expansion of precision oncology and multidisciplinary cancer care is further increasing the need for interoperable platforms that connect imaging data with EHRs, oncology information systems, and other clinical applications.
"Asia Pacific to witness the highest growth rate during the forecast period."
The Asia Pacific region is projected to post the highest growth rate in the enterprise imaging IT market over the forecast period, supported by rapid healthcare digitalization, expanding diagnostic imaging infrastructure, and growing adoption of cloud-based and AI-enabled imaging solutions. China is accelerating the development of regional medical imaging infrastructure, with the National Health Commission reporting that medical imaging centers now cover more than 70% of township health centers, enabling greater sharing of diagnostic resources between primary and higher-level facilities. In August 2025, China's National Healthcare Security Administration reported that 22 provinces had deployed software for a national medical imaging cloud-sharing pathway, with 17 provinces enabling cross-provincial access to imaging data and more than 18.48 million imaging index records aggregated nationally. India is also expanding its digital healthcare infrastructure; as of July 2026, more than 948.7 million ABHA accounts and 536,000 healthcare facilities had been registered under the Ayushman Bharat Digital Mission, strengthening the digital ecosystem required for interoperable healthcare data exchange. Furthermore, China is promoting AI-enabled medical imaging, including intelligent image-assisted diagnosis and report generation, while Japan and other technologically advanced Asia Pacific markets continue to strengthen enterprise imaging and PACS infrastructure. These developments, alongside rising imaging volumes, expanding multi-site healthcare networks, growing teleradiology adoption, and demand for interoperable image-sharing platforms, are expected to accelerate adoption of enterprise imaging IT solutions across Asia Pacific.
The breakdown of primary participants is as mentioned below:
- By Company Type - Tier 1: 34%, Tier 2: 46%, and Tier 3: 20%
- By Designation - C-level: 35%, Director-level: 25%, and Others: 40%
- By Region - North America: 30%, Europe: 45%, Asia Pacific: 20%, Middle East & Africa: 3%, Latin America: 2%
Key Players in the Enterprise Imaging IT Market
The key players functioning in the enterprise imaging IT market include Agfa-Gevaert Group. (Belgium), FUJIFILM Corporation (Japan), Merative (US), Pro Medicus, Ltd. (Australia), Optum, Inc. (US), GE HealthCare (US), Sectra AB (Sweden), CANON MEDICAL SYSTEMS CORPORATION (Japan), Hyland Software, Inc. (US), Koninklijke Philips N.V. (Netherlands), among others.
Research Coverage:
The scope of the report covers detailed information on the major factors, such as drivers, restraints, challenges, and opportunities, that influence the growth of the enterprise imaging IT market. A detailed analysis of key industry players has been conducted to provide insights into their business overview, solutions, and services; key strategies; contracts, partnerships, and agreements; new product and service launches; mergers and acquisitions; and recent developments associated with the enterprise imaging IT market. The report also covers a competitive analysis of upcoming startups in the enterprise imaging IT market ecosystem.
Reasons to Buy the Report
This report will help established firms and new or smaller entrants gauge the market's pulse, which, in turn, would help them gain a greater share of the market. Firms purchasing the report could use one or more of the strategies mentioned below to strengthen their positions in the market.
This report provides insights on:
- Analysis of key drivers (growing volume of medical imaging procedures, increasing demand for scalable and cost-effective solutions, increasing adoption of cloud-based enterprise imaging solutions), restraints (data security and privacy concerns, lack of skilled professionals for deployment and interpretation), opportunities (growth of vendor-neutral archives (VNA) and interoperability, increasing adoption of AI-enabled imaging and advanced visualization), and challenges (limited adoption in developing regions, high upfront integration and deployment costs) influencing the growth of the enterprise imaging IT market.
- Product Development/Innovation: Detailed insights into upcoming technologies, R&D activities, and new product launches in the enterprise imaging IT market.
- Market Development: Comprehensive information on the lucrative emerging markets, function, modality, application, offering, deployment mode, therapeutic area, end-users, and regions.
- Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the enterprise imaging IT market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the enterprise imaging IT market such as Agfa-Gevaert Group. (Belgium), FUJIFILM Corporation (Japan), Merative (US), Pro Medicus, Ltd. (Australia), Optum, Inc. (US), GE HealthCare (US), Sectra AB (Sweden), CANON MEDICAL SYSTEMS CORPORATION (Japan), Hyland Software, Inc. (US), Koninklijke Philips N.V. (Netherlands), among others.
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 STUDY OBJECTIVES
- 1.2 MARKET DEFINITION
- 1.3 MARKET SCOPE
- 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
- 1.3.2 INCLUSIONS & EXCLUSIONS
- 1.4 YEARS CONSIDERED
- 1.5 CURRENCY
- 1.6 STAKEHOLDERS
- 1.7 SUMMARY OF CHANGES
2 EXECUTIVE SUMMARY
- 2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS
- 2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS
- 2.3 DISRUPTIVE TRENDS SHAPING THE MARKET
- 2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS
- 2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST
3 PREMIUM INSIGHTS
- 3.1 ENTERPRISE IMAGING IT MARKET OVERVIEW
- 3.2 ENTERPRISE IMAGING IT MARKET, BY APPLICATION & REGION
- 3.3 ENTERPRISE IMAGING IT MARKET: GEOGRAPHIC SNAPSHOT
4 MARKET OVERVIEW
- 4.1 INTRODUCTION
- 4.2 MARKET DYNAMICS
- 4.2.1 DRIVERS
- 4.2.1.1 Increased demand for scalable and cost-effective solutions
- 4.2.1.2 Advancements in AI and imaging technologies
- 4.2.1.3 Growing volume of medical imaging procedures
- 4.2.1.4 Growing need for remote access and collaborative care
- 4.2.1.5 Government initiatives and favorable policies
- 4.2.2 RESTRAINTS
- 4.2.2.1 Data security and privacy concerns
- 4.2.2.2 Lack of skilled professionals for deployment and interpretation
- 4.2.3 OPPORTUNITIES
- 4.2.3.1 Expansion into emerging markets
- 4.2.3.2 Multi modality and advanced visualization
- 4.2.3.3 Partnerships with AI and analytics providers
- 4.2.3.4 Value-based care and population health management
- 4.2.3.5 Cloud native and edge computing innovations
- 4.2.4 CHALLENGES
- 4.2.4.1 Interoperability with legacy and vendor-specific systems
- 4.2.4.2 High upfront integration and deployment costs
- 4.2.4.3 Workflow disruption and user adoption
- 4.3 UNMET NEEDS AND WHITE SPACES
- 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
- 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5 INDUSTRY TRENDS
- 5.1 PORTER'S FIVE FORCES ANALYSIS
- 5.1.1 BARGAINING POWER OF SUPPLIERS
- 5.1.2 BARGAINING POWER OF BUYERS
- 5.1.3 THREAT OF SUBSTITUTES
- 5.1.4 THREAT OF NEW ENTRANTS
- 5.1.5 INTENSITY OF COMPETITIVE RIVALRY
- 5.2 MACROECONOMIC INDICATORS
- 5.2.1 INTRODUCTION
- 5.2.2 GDP TRENDS AND FORECAST
- 5.2.3 TRENDS IN GLOBAL HEALTHCARE IT INDUSTRY
- 5.3 VALUE CHAIN ANALYSIS
- 5.4 ECOSYSTEM ANALYSIS
- 5.5 PRICING ANALYSIS
- 5.5.1 INDICATIVE PRICING FOR ENTERPRISE IMAGING IT MARKET, BY OFFERING (2025)
- 5.5.2 INDICATIVE PRICING FOR ENTERPRISE IMAGING IT SOLUTIONS, BY REGION (2025)
- 5.6 KEY CONFERENCES AND EVENTS, 2026-2027
- 5.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
- 5.8 INVESTMENT AND FUNDING SCENARIO
- 5.9 CASE STUDY ANALYSIS
- 5.10 IMPACT OF 2025 US TARIFFS ON ENTERPRISE IMAGING IT MARKET
- 5.10.1 INTRODUCTION
- 5.10.2 KEY TARIFF RATES
- 5.10.3 PRICE IMPACT ANALYSIS
- 5.10.3.1 Increased costs of hardware components
- 5.10.3.2 Software & licensing inflation
- 5.10.3.3 Supply chain disruption
- 5.10.4 IMPACT ON COUNTRY/REGION
- 5.10.4.1 US
- 5.10.4.2 Europe
- 5.10.4.3 Asia Pacific
- 5.10.5 IMPACT ON END USERS
- 5.10.5.1 Hospitals (large, mid-sized, and academic medical centers)
- 5.10.5.2 Diagnostic centers (independent and chain-based)
- 5.10.5.3 Teleradiology providers
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
- 6.1 KEY EMERGING TECHNOLOGIES
- 6.1.1 IMAGING ANALYTICS PLATFORMS
- 6.1.2 ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING
- 6.1.3 MULTI MODALITY FUSION & CO REGISTRATION ENGINES
- 6.1.4 ZERO FOOTPRINT VIEWERS
- 6.1.5 MOBILE ENTERPRISE IMAGING AND WORKFLOW BOTS
- 6.2 COMPLEMENTARY TECHNOLOGIES
- 6.2.1 RADIOLOGY INFORMATION SYSTEMS (RIS)
- 6.2.2 ELECTRONIC HEALTH RECORD (EHR/EMR) INTEGRATION
- 6.3 ADJACENT TECHNOLOGIES
- 6.3.1 CLOUD COMPUTING & STORAGE
- 6.3.2 BLOCKCHAIN & DISTRIBUTED LEDGER TECHNOLOGY
- 6.4 TECHNOLOGY/PRODUCT ROADMAP
- 6.5 PATENT ANALYSIS
- 6.5.1 PATENT PUBLICATION TRENDS FOR ENTERPRISE IMAGING IT MARKET
- 6.5.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
- 6.6 FUTURE APPLICATIONS
- 6.6.1 AI-DRIVEN IMAGE ANALYSIS & CLINICAL DECISION SUPPORT
- 6.6.2 CLOUD-BASED IMAGING & ENTERPRISE-WIDE DATA MANAGEMENT
- 6.6.3 MULTIDISCIPLINARY IMAGING & INTEROPERABLE CLINICAL WORKFLOWS
- 6.6.4 ADVANCED VISUALIZATION, DIGITAL PATHOLOGY, AND PRECISION HEALTHCARE
- 6.6.5 AUTOMATED IMAGING WORKFLOWS & INTELLIGENT DATA GOVERNANCE
- 6.7 IMPACT OF GENERATIVE AI ON ENTERPRISE IMAGING IT MARKET
- 6.7.1 INTRODUCTION
- 6.7.2 TOP USE CASES & MARKET POTENTIAL
- 6.7.3 CASE STUDIES OF AI/GENERATIVE AI IMPLEMENTATION
- 6.7.3.1 Case Study 1: Enabling interoperability and scalability across enterprise imaging networks with Dicom Systems' Unifier Platform
- 6.7.3.2 Case Study 2: San Gerardo Hospital transforms radiology with Agfa HealthCare's Enterprise Imaging
- 6.7.4 INTERCONNECTED & ADJACENT MARKETS
- 6.7.4.1 Vendor-neutral Archive (VNA) & PACS market
- 6.7.4.2 Medical image analysis software market
- 6.7.4.3 Healthcare IT market
- 6.7.5 USER READINESS & IMPACT ASSESSMENT
- 6.7.5.1 User readiness
- 6.7.5.1.1 User A: Hospitals
- 6.7.5.1.2 User B: Diagnostic centers
- 6.7.5.2 Impact assessment
- 6.7.5.2.1 User A: Hospitals
- 6.7.5.2.1.1 Implementation
- 6.7.5.2.1.2 Impact
- 6.7.5.2.2 User B: Diagnostic centers
- 6.7.5.2.2.1 Implementation
- 6.7.5.2.2.2 Impact
7 REGULATORY LANDSCAPE
- 7.1 REGIONAL REGULATIONS AND COMPLIANCE
- 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, & OTHER ORGANIZATIONS
- 7.1.2 REGULATORY FRAMEWORK
- 7.1.2.1 North America
- 7.1.2.2 Europe
- 7.1.2.3 Asia Pacific
- 7.1.2.4 Latin America
- 7.1.2.5 Middle East & Africa
- 7.1.3 INDUSTRY STANDARDS
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR
- 8.1 INTRODUCTION
- 8.2 DECISION-MAKING PROCESS
- 8.3 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
- 8.3.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 8.3.2 BUYING CRITERIA
- 8.4 ADOPTION BARRIERS & INTERNAL CHALLENGES
- 8.5 UNMET NEEDS FROM VARIOUS END USERS
- 8.5.1 UNMET NEEDS
- 8.5.2 END USER EXPECTATIONS
- 8.6 MARKET PROFITABILITY
9 ENTERPRISE IMAGING IT MARKET, BY FUNCTION
- 9.1 INTRODUCTION
- 9.2 VENDOR-NEUTRAL ARCHIVES (VNA)
- 9.2.1 ADVANCING SEAMLESS INFORMATION EXCHANGE THROUGH VNA SOLUTIONS TO BOOST MARKET GROWTH
- 9.3 PICTURE ARCHIVING AND COMMUNICATION SYSTEMS (PACS)
- 9.3.1 GROWING INTEGRATION OF AI WITHIN PACS FOR OPTIMIZED RADIOLOGY WORKFLOWS TO SUPPORT MARKET GROWTH
- 9.4 IMAGE EXCHANGE
- 9.4.1 GROWING POPULARITY OF INTEROPERABLE IMAGING NETWORKS FOR PATIENT-CENTERED DATA SHARING TO DRIVE GROWTH
- 9.5 UNIVERSAL VIEWERS
- 9.5.1 GROWING UNIVERSAL VIEWER DEPLOYMENT FOR MULTI-DISCIPLINARY IMAGING TO FUEL MARKET
- 9.6 WORKFLOW ORCHESTRATION
- 9.6.1 AI-POWERED IMAGING WORKFLOW AUTOMATION AND CROSS-MODALITY COORDINATION TO PROPEL MARKET
- 9.7 ANALYTICS
- 9.7.1 GROWING NEED FOR ANALYTICS PLATFORMS FOR VALUE-BASED IMAGING AND OPERATIONAL OPTIMIZATION TO DRIVE MARKET
- 9.8 OTHER FUNCTIONS
10 ENTERPRISE IMAGING IT MARKET, BY MODALITY
- 10.1 INTRODUCTION
- 10.2 X-RAY
- 10.2.1 GROWTH IN ENTERPRISE IMAGING THROUGH AI-ENABLED X-RAY SOLUTIONS TO BOOST MARKET
- 10.3 MAGNETIC RESONANCE IMAGING (MRI)
- 10.3.1 EXPANDING MRI ENTERPRISE IT TO MEET RISING NEUROLOGICAL IMAGING DEMANDS TO SUPPORT MARKET GROWTH
- 10.4 COMPUTED TOMOGRAPHY (CT)
- 10.4.1 REGULATORY AND VALUE-BASED INCENTIVES TO FUEL CT IMAGING IT ADOPTION
- 10.5 ULTRASOUND
- 10.5.1 AI-POWERED ULTRASOUND AND POCUS TO ACCELERATE ENTERPRISE IMAGING TRANSFORMATION
- 10.6 NUCLEAR IMAGING
- 10.6.1 POSITRON EMISSION TOMOGRAPHY (PET)
- 10.6.1.1 Rising PET scan volumes to drive demand for scalable, intelligent Imaging IT
- 10.6.2 SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT)
- 10.6.2.1 Driving diagnostic accuracy with automated SPECT workflows to contribute to growth
- 10.7 ENDOSCOPY
- 10.7.1 ENABLING REAL-TIME ENDOSCOPIC INSIGHTS THROUGH CLOUD-NATIVE VIDEO ORCHESTRATION TO DRIVE MARKET
- 10.8 MAMMOGRAPHY
- 10.8.1 NEED FOR ENTERPRISE IMAGING SOLUTIONS FOR HIGH-VOLUME, HIGH-RESOLUTION MAMMOGRAPHY WORKFLOWS TO FUEL GROWTH
- 10.9 FLUOROSCOPY
- 10.9.1 STRATEGIC CLOUD-NATIVE IMAGING FOR ADVANCED FLUOROSCOPY USE CASES TO AID WITH GROWTH
- 10.10 ECHOCARDIOGRAPHY
- 10.10.1 ABILITY TO ENHANCE FLUOROSCOPY IMAGING EFFICIENCY WITH AI-INTEGRATED ENTERPRISE IT SOLUTIONS TO BOOST MARKET
- 10.11 OTHER MODALITIES
11 ENTERPRISE IMAGING IT MARKET, BY APPLICATION
- 11.1 INTRODUCTION
- 11.2 DIAGNOSTICS
- 11.2.1 AI-ENABLED QUANTIFICATION AND INTEGRATED THERANOSTIC WORKFLOWS TO DRIVE DIAGNOSTIC IMAGING TRANSFORMATION
- 11.3 THERAPEUTICS
- 11.3.1 ADVANTAGES SUCH AS MULTIMODAL TREATMENT INTEGRATION TO OPTIMIZE ENTERPRISE IMAGING FOR THERAPEUTIC WORKFLOWS
- 11.4 CLINICAL RESEARCH
- 11.4.1 AI-ENABLED QUANTIFICATION AND RAPID-RESPONSE IMAGING WORKFLOWS TO ACCELERATE CLINICAL RESEARCH
12 ENTERPRISE IMAGING IT MARKET, BY OFFERING
- 12.1 INTRODUCTION
- 12.2 SOFTWARE
- 12.2.1 ADVANCING UNIFIED IMAGING ECOSYSTEMS THROUGH CLOUD-NATIVE SOFTWARE TO BOOST MARKET GROWTH
- 12.3 SERVICES
- 12.3.1 ADVANTAGES SUCH AS EXPERT SERVICES, CLOUD MIGRATION, AND WORKFLOW OPTIMIZATION TO SUPPORT MARKET GROWTH
13 ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE
- 13.1 INTRODUCTION
- 13.2 ON-PREMISE SOLUTIONS
- 13.2.1 GROWING NEED FOR IMAGING PERFORMANCE AND DATA CONTROL THROUGH ON-PREMISE DEPLOYMENT TO SUPPORT MARKET GROWTH
- 13.3 CLOUD-BASED SOLUTIONS
- 13.3.1 RISING NEED FOR COST-EFFICIENT, SCALABLE INFRASTRUCTURE TO DRIVE DEMAND FOR CLOUD-BASED DEPLOYMENT
- 13.4 HYBRID SOLUTIONS
- 13.4.1 ABILITY TO BRIDGE DATA CONTROL AND CLOUD INNOVATION THROUGH HYBRID DEPLOYMENT TO BOOST GROWTH
14 ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA
- 14.1 INTRODUCTION
- 14.2 NEUROLOGY
- 14.2.1 INTEGRATION OF AI-DRIVEN MULTIMODAL NEUROIMAGING FOR PERSONALIZED NEUROLOGICAL CARE TO BOOST MARKET
- 14.3 CARDIOLOGY
- 14.3.1 CLOUD-ENABLED, AI-DRIVEN ENTERPRISE IMAGING PLATFORMS TO ACCELERATE ADVANCED CARDIAC DIAGNOSTICS
- 14.4 ONCOLOGY
- 14.4.1 AI-DRIVEN, MULTIMODAL ENTERPRISE IMAGING PLATFORMS TO ADVANCE PRECISION ONCOLOGY
- 14.5 ORTHOPEDICS
- 14.5.1 ABILITY OF AI-ENABLED ENTERPRISE IMAGING PLATFORMS TO TRANSFORM ORTHOPEDIC CARE TO DRIVE DEMAND
- 14.6 OTHER THERAPEUTIC AREAS
15 ENTERPRISE IMAGING IT MARKET, BY END USER
- 15.1 INTRODUCTION
- 15.2 HOSPITALS
- 15.2.1 HOSPITALS TO DRIVE DEMAND FOR UNIFIED IMAGING INFRASTRUCTURE TO SUPPORT INTEGRATED CARE DELIVERY
- 15.3 DIAGNOSTIC CENTERS
- 15.3.1 GROWING ADOPTION OF ENTERPRISE IMAGING IT TO ENHANCE WORKFLOW EFFICIENCY IN DIAGNOSTIC CENTERS TO BOOST MARKET
- 15.4 CLINICS & OUTPATIENT SETTINGS
- 15.4.1 GROWING POPULARITY OF LIGHTWEIGHT ENTERPRISE IMAGING IT TO BOOST EFFICIENCY AND PATIENT THROUGHPUT TO FUEL GROWTH
- 15.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
- 15.5.1 GROWING USE OF ENTERPRISE IMAGING IT FOR TRANSLATIONAL RESEARCH AND DRUG DEVELOPMENT TO DRIVE MARKET
- 15.6 MEDTECH COMPANIES
- 15.6.1 ABILITY OF ENTERPRISE IMAGING IT TO ACCELERATE DEVICE INNOVATION AND CLINICAL INTEGRATION TO FUEL ADOPTION
- 15.7 RESEARCH & ACADEMIC INSTITUTES
- 15.7.1 GROWING NEED TO POWER DATA-DRIVEN DISCOVERY AND COLLABORATION TO SUPPORT MARKET GROWTH
- 15.8 OTHER END USERS
16 ENTERPRISE IMAGING IT MARKET, BY REGION
- 16.1 INTRODUCTION
- 16.2 NORTH AMERICA
- 16.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
- 16.2.2 US
- 16.2.2.1 AI integration, cloud adoption, and regulatory push to accelerate enterprise imaging IT transformation in US
- 16.2.3 CANADA
- 16.2.3.1 Provincial interoperability mandates and cloud-enabled AI to drive growth in Canada's imaging IT market
- 16.3 EUROPE
- 16.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
- 16.3.2 GERMANY
- 16.3.2.1 Hospital modernization and ePA adoption to propel Germany's enterprise imaging IT growth
- 16.3.3 UK
- 16.3.3.1 NHS push for AI-driven imaging and cloud integration to fuel market growth
- 16.3.4 FRANCE
- 16.3.4.1 Accelerated cloud-native, interoperable imaging platforms with focus on data sovereignty to drive market
- 16.3.5 ITALY
- 16.3.5.1 Growing VNA and teleradiology adoption in Italy to modernize imaging infrastructure
- 16.3.6 SPAIN
- 16.3.6.1 Spain to scale cloud imaging and VNA for regional collaboration
- 16.3.7 REST OF EUROPE
- 16.4 ASIA PACIFIC
- 16.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
- 16.4.2 CHINA
- 16.4.2.1 AI diagnostic approvals to accelerate market growth
- 16.4.3 JAPAN
- 16.4.3.1 Aging demographics to drive demand for scalable imaging solutions
- 16.4.4 INDIA
- 16.4.4.1 Government-led digitization to fuel imaging infrastructure expansion
- 16.4.5 REST OF ASIA PACIFIC
- 16.5 LATIN AMERICA
- 16.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
- 16.5.2 BRAZIL
- 16.5.2.1 Government investments to accelerate public health digitization drives
- 16.5.3 MEXICO
- 16.5.3.1 Accelerating imaging modernization through nationwide digital integration in Mexico to boost market
- 16.5.4 REST OF LATIN AMERICA
- 16.6 MIDDLE EAST & AFRICA
- 16.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
- 16.6.2 GCC COUNTRIES
- 16.6.2.1 Enterprise imaging adoption accelerates across GCC amid workforce gaps and digital health push to support growth
- 16.6.3 REST OF MIDDLE EAST & AFRICA
17 COMPETITIVE LANDSCAPE
- 17.1 OVERVIEW
- 17.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2023-2026
- 17.3 REVENUE ANALYSIS, 2021-2025
- 17.4 MARKET SHARE ANALYSIS, 2025
- 17.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
- 17.5.1 STARS
- 17.5.2 EMERGING LEADERS
- 17.5.3 PERVASIVE PLAYERS
- 17.5.4 PARTICIPANTS
- 17.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
- 17.5.5.1 Company footprint
- 17.5.5.2 Region footprint
- 17.5.5.3 Function footprint
- 17.5.5.4 Application footprint
- 17.5.5.5 Therapeutic footprint
- 17.5.5.6 Deployment footprint
- 17.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
- 17.6.1 PROGRESSIVE COMPANIES
- 17.6.2 RESPONSIVE COMPANIES
- 17.6.3 DYNAMIC COMPANIES
- 17.6.4 STARTING BLOCKS
- 17.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
- 17.6.5.1 Detailed list of key startups/SMEs
- 17.6.5.2 Competitive benchmarking of startups/SMEs
- 17.7 VALUATION & FINANCIAL METRICS
- 17.7.1 FINANCIAL METRICS
- 17.7.2 COMPANY VALUATION
- 17.8 BRAND/SOFTWARE COMPARISON
- 17.9 COMPETITIVE SCENARIO
- 17.9.1 SOLUTION LAUNCHES & ENHANCEMENT
- 17.9.2 DEALS
- 17.9.3 EXPANSIONS
- 17.9.4 OTHER DEVELOPMENTS
18 COMPANY PROFILES
- 18.1 KEY PLAYERS
- 18.1.1 AGFA-GEVAERT GROUP
- 18.1.1.1 Business overview
- 18.1.1.2 Solutions offered
- 18.1.1.3 Recent developments
- 18.1.1.4 MnM view
- 18.1.1.4.1 Key strengths
- 18.1.1.4.2 Strategic choices
- 18.1.1.4.3 Weaknesses & competitive threats
- 18.1.2 FUJIFILM HOLDINGS CORPORATION
- 18.1.2.1 Business overview
- 18.1.2.2 Solutions offered
- 18.1.2.3 Recent developments
- 18.1.2.3.1 Solution launches
- 18.1.2.3.2 Deals
- 18.1.2.4 MnM view
- 18.1.2.4.1 Key strengths
- 18.1.2.4.2 Strategic choices
- 18.1.2.4.3 Weaknesses & competitive threats
- 18.1.3 GE HEALTHCARE
- 18.1.3.1 Business overview
- 18.1.3.2 Solutions offered
- 18.1.3.3 Recent developments
- 18.1.3.3.1 Solution launches & approvals
- 18.1.3.3.2 Deals
- 18.1.3.4 MnM view
- 18.1.3.4.1 Key strengths
- 18.1.3.4.2 Strategic choices
- 18.1.3.4.3 Weaknesses & competitive threats
- 18.1.4 KONINKLIJKE PHILIPS N.V.
- 18.1.4.1 Business overview
- 18.1.4.2 Solutions offered
- 18.1.4.3 Recent developments
- 18.1.4.3.1 Solution launches & approvals
- 18.1.4.3.2 Deals
- 18.1.4.3.3 Expansions
- 18.1.4.4 MnM view
- 18.1.4.4.1 Key strengths
- 18.1.4.4.2 Strategic choices
- 18.1.4.4.3 Weaknesses & competitive threats
- 18.1.5 SIEMENS HEALTHINEERS AG
- 18.1.5.1 Business overview
- 18.1.5.2 Solutions offered
- 18.1.5.3 Recent developments
- 18.1.5.3.1 Solution launches
- 18.1.5.3.2 Deals
- 18.1.5.4 MnM view
- 18.1.5.4.1 Key strengths
- 18.1.5.4.2 Strategic choices
- 18.1.5.4.3 Weaknesses & competitive threats
- 18.1.6 SECTRA AB
- 18.1.6.1 Business overview
- 18.1.6.2 Solutions offered
- 18.1.6.3 Recent developments
- 18.1.6.3.1 Solution launches & approvals
- 18.1.6.3.2 Deals
- 18.1.6.3.3 Other developments
- 18.1.7 OPTUM, INC.
- 18.1.7.1 Business overview
- 18.1.7.2 Solutions offered
- 18.1.7.3 Recent developments
- 18.1.8 CANON MEDICAL SYSTEMS CORPORATION
- 18.1.8.1 Business overview
- 18.1.8.2 Solutions offered
- 18.1.8.3 Recent developments
- 18.1.9 MERATIVE
- 18.1.9.1 Business overview
- 18.1.9.2 Solutions offered
- 18.1.9.3 Recent developments
- 18.1.9.3.1 Solution launches
- 18.1.9.3.2 Deals
- 18.1.9.3.3 Expansions
- 18.1.10 PRO MEDICUS, LTD.
- 18.1.10.1 Business overview
- 18.1.10.2 Solutions offered
- 18.1.10.3 Recent developments
- 18.1.10.3.1 Solution launches
- 18.1.10.3.2 Deals
- 18.1.11 HYLAND
- 18.1.11.1 Business overview
- 18.1.11.2 Solutions offered
- 18.1.11.3 Recent developments
- 18.1.11.3.1 Solution launches
- 18.1.11.3.2 Deals
- 18.1.11.3.3 Expansions
- 18.1.12 INFINITT HEALTHCARE CO., LTD.
- 18.1.12.1 Business overview
- 18.1.12.2 Recent developments
- 18.1.12.2.1 Solution launches & approvals
- 18.1.12.2.2 Deals
- 18.1.13 NOVARAD
- 18.1.13.1 Business overview
- 18.1.13.2 Solutions offered
- 18.1.13.3 Recent developments
- 18.1.13.3.1 Solution launches
- 18.1.13.3.2 Deals
- 18.1.14 MACH7 TECHNOLOGIES
- 18.1.14.1 Business overview
- 18.1.14.2 Solutions offered
- 18.1.14.3 Recent developments
- 18.1.14.3.1 Solution launches
- 18.1.14.3.2 Deals
- 18.1.15 HERMES MEDICAL SOLUTIONS
- 18.1.15.1 Business overview
- 18.1.15.2 Solutions offered
- 18.1.15.3 Recent developments
- 18.1.15.3.1 Solution launches, approvals, and enhancements
- 18.1.15.3.2 Deals
- 18.1.16 KONICA MINOLTA, INC.
- 18.1.16.1 Business overview
- 18.1.16.2 Solutions offered
- 18.1.16.3 Recent developments
- 18.1.16.3.1 Solution launches & enhancements
- 18.1.16.3.2 Deals
- 18.1.16.3.3 Expansions
- 18.1.16.3.4 Other developments
- 18.1.17 BRIDGEHEAD SOFTWARE LTD.
- 18.1.17.1 Business overview
- 18.1.17.2 Solutions offered
- 18.1.17.3 Recent developments
- 18.1.18 SCIMAGE, INC.
- 18.1.18.1 Business overview
- 18.1.18.2 Solutions offered
- 18.1.18.3 Recent developments
- 18.1.18.3.1 Solution launches
- 18.1.18.3.2 Deals
- 18.1.19 RAMSOFT INC.
- 18.1.19.1 Business overview
- 18.1.19.2 Solutions offered
- 18.1.19.3 Recent developments
- 18.1.19.3.1 Solution launches & enhancements
- 18.1.19.3.2 Deals
- 18.1.20 DICOM SYSTEMS, INC.
- 18.1.20.1 Business overview
- 18.1.20.2 Solutions offered
- 18.1.20.3 Recent developments
- 18.2 OTHER PLAYERS
- 18.2.1 POSTDICOM B.V.
- 18.2.2 QAELUM
- 18.2.3 ADVAHEALTH SOLUTIONS
- 18.2.4 PAXERAHEALTH
- 18.2.5 RAD AI
19 RESEARCH METHODOLOGY
- 19.1 RESEARCH DATA
- 19.1.1 SECONDARY DATA
- 19.1.1.1 Key data from secondary sources
- 19.1.2 PRIMARY DATA
- 19.1.2.1 Key data from primary sources
- 19.1.2.2 Breakdown of primary sources
- 19.2 RESEARCH APPROACH
- 19.3 MARKET SIZE ESTIMATION
- 19.4 MARKET BREAKDOWN & DATA TRIANGULATION
- 19.5 MARKET SHARE ESTIMATION
- 19.6 STUDY ASSUMPTIONS
- 19.7 RESEARCH LIMITATIONS
- 19.7.1 METHODOLOGY-RELATED LIMITATIONS
- 19.7.2 SCOPE-RELATED LIMITATIONS
- 19.8 RISK ASSESSMENT
20 APPENDIX
- 20.1 DISCUSSION GUIDE
- 20.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
- 20.3 CUSTOMIZATION OPTIONS
- 20.4 RELATED REPORTS
- 20.5 AUTHOR DETAILS